ARMK.NYSEAramark

Form 4: Aramark Director Karen King's Equity Transactions

Sentiment:

Insider Transaction Report


📋All filings for Aramark

Aramark Director Karen King reported the acquisition of 5,124 deferred stock units and the disposition of 32.211 shares for tax purposes.

Summary

  • Karen Marie King, a Director of Aramark, reported transactions involving the company's common stock.
  • On February 2, 2026, 32.211 shares of common stock were disposed of at a price of $38.49 per share. This disposition was for tax withholding related to the vesting of deferred stock units.
  • On February 3, 2026, 5,124 deferred stock units (DSUs) were granted at a price of $38.06 per unit.
  • These DSUs will vest on the day prior to the first annual stockholders' meeting occurring after the grant date, contingent on continued service, and will be settled in common stock upon vesting.
  • Following these transactions, Karen King beneficially owns 42,743.128 shares of Aramark common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting a routine equity grant to a director, which aligns their interests with shareholders, offset by a standard tax-related disposition.

Positives

  • Grant of 5,124 deferred stock units to a director, aligning management interests with shareholders.

Negatives

  • Disposition of 32.211 shares for tax withholding purposes, which is a routine event related to equity compensation vesting.

Future Outlook

The granted deferred stock units are subject to vesting on the day prior to the first annual stockholders' meeting occurring after the grant date, contingent on continued service, and will be settled in shares of common stock upon vesting.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as equity grants and tax-related dispositions, are common across industries and typically reflect standard executive compensation practices rather than specific market or company-specific trends. These transactions are part of a director's compensation package and aim to align their interests with long-term shareholder value.

Comparison to Industry Standards

  • StockSavvy.ai observes that the grant of deferred stock units to a director is a standard practice in corporate governance, similar to compensation structures seen at peer companies in the food services and facilities management sector like Compass Group PLC or Sodexo S.A.
  • The tax withholding related to vesting is also a routine, non-discretionary event.
  • The specific number of units granted and the vesting schedule are consistent with typical long-term incentive plans for non-employee directors in large public companies.

Stakeholder Impact

  • Shareholders: The grant of equity to a director aligns their interests with shareholders, potentially fostering long-term value creation.
  • Employees: No direct impact on general employees is indicated by this filing.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

  • Vesting of deferred stock units on the day prior to the first annual stockholders' meeting of Aramark occurring after February 3, 2026, subject to continued service.
  • Settlement of vested deferred stock units in shares of common stock on the vesting date.

Key Dates

DateDescription
02/02/2026Transaction date for disposition of shares for tax withholding.
02/03/2026Transaction date for grant of deferred stock units.
02/04/2026Signature date of the reporting person's attorney-in-fact.
Vesting Date (post-02/03/2026)Deferred stock units will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service.

Recommendation

hold

This Form 4 filing details routine insider transactions for a director, including an equity grant and a tax-related disposition. Such transactions are standard components of executive compensation and do not typically signal a material change in the company's fundamental outlook or operational performance. Therefore, it provides no new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation.

Keywords

Aramark, ARMK, Form 4, Insider Trading, Director, Equity Grant, Deferred Stock Units, Stock Transaction, Karen King

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.